NasdaqCM - Nasdaq Real Time Price USD

OpGen, Inc. (OPGN)

0.4986 -0.0334 (-6.28%)
As of 3:30 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
3,070.2310
2,607.2930
4,306.0310
4,214.4410
Cost of Revenue
2,867.1120
3,423.9910
2,848.4480
3,848.4910
Gross Profit
203.1190
-816.6980
1,457.5830
365.9500
Operating Expense
18,558.3620
21,402.1750
24,559.9050
21,860.4730
Operating Income
-18,355.2430
-22,218.8730
-23,102.3220
-21,494.5230
Net Non Operating Interest Income Expense
-2,231.0860
-3,209.4750
-4,754.1520
-3,293.7570
Other Income Expense
-5,575.6740
-11,854.8850
-6,905.4100
-1,290.1610
Pretax Income
-26,162.0030
-37,283.2330
-34,761.8840
-26,078.4410
Tax Provision
--
--
43.8280
132.4030
Net Income Common Stockholders
-26,162.0030
-37,283.2330
-41,972.4640
-26,210.8440
Diluted NI Available to Com Stockholders
-26,162.0030
-37,283.2330
-41,972.4640
-26,210.8440
Basic EPS
-6.25
-15.27
-22.80
-33.20
Diluted EPS
-6.25
-15.27
-22.80
-33.20
Basic Average Shares
5,606.6240
2,441.5800
1,833.7040
790.0390
Diluted Average Shares
5,606.6240
2,441.5800
1,833.7040
790.0390
Total Operating Income as Reported
-23,727.9710
-34,567.1210
-23,273.0360
-22,718.4790
Total Expenses
21,425.4740
24,826.1660
27,408.3530
25,708.9640
Net Income from Continuing & Discontinued Operation
-26,162.0030
-37,283.2330
-34,805.7120
-26,210.8440
Normalized Income
-20,586.3290
-25,428.3480
-29,764.7627
-24,927.1338
Interest Income
105.0890
46.9350
45.1790
105.6270
Interest Expense
2,336.1750
3,256.4100
4,799.3310
3,399.3840
Net Interest Income
-2,231.0860
-3,209.4750
-4,754.1520
-3,293.7570
EBIT
-23,825.8280
-34,026.8230
-29,962.5530
-22,679.0570
EBITDA
-22,420.0560
-32,384.0420
-27,248.6460
-20,344.3180
Reconciled Cost of Revenue
2,867.1120
3,423.9910
2,848.4480
3,848.4910
Reconciled Depreciation
1,405.7720
1,642.7810
2,713.9070
2,334.7390
Net Income from Continuing Operation Net Minority Interest
-26,162.0030
-37,283.2330
-34,805.7120
-26,210.8440
Total Unusual Items Excluding Goodwill
-5,575.6740
-11,854.8850
-6,905.4100
-1,290.1610
Total Unusual Items
-5,575.6740
-11,854.8850
-6,905.4100
-1,290.1610
Normalized EBITDA
-16,844.3820
-20,529.1570
-20,343.2360
-19,054.1570
Tax Rate for Calcs
--
--
0.0003
0.0000
Tax Effect of Unusual Items
--
--
-1,864.4607
-6.4508
12/31/2020 - 5/5/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SINT Sintx Technologies, Inc.
0.0410
+12.02%
 
NAOV NanoVibronix, Inc.
0.7502
-2.32%
 
BIOL BIOLASE, Inc.
0.1461
-1.28%
 
HSCS Heart Test Laboratories, Inc.
0.0965
-3.40%
 
INBS Intelligent Bio Solutions Inc.
2.7099
+8.83%
 
NUWE Nuwellis, Inc.
0.1690
-41.52%
 
TIVC Tivic Health Systems, Inc.
1.0400
-3.70%
 
VVOS Vivos Therapeutics, Inc.
2.4815
-0.14%
 
AIMD Ainos, Inc.
1.0300
-1.90%
 
BSGM BioSig Technologies, Inc.
1.3900
+6.98%